OPERON ELEVATEPLUS | REGULATORY DUE DILIGENCE FOR MEDICAL DEVICES
Medical Device Regulatory Due Diligence & IVD Assessments
Operon Strategist delivers structured Regulatory Due Diligence services, built on medical device regulatory consulting experience, that provide clear visibility into regulatory status, compliance maturity, approval dependencies, and hidden risks. Our assessments go beyond checklists, offering decision-grade intelligence that supports confident investment decisions, deal structuring, and post-transaction planning.
Take the next step
Operon ElevatePlus
Medical Device Regulatory Assessment Service Portfolio
Our medical device regulatory due diligence covers seven areas, from approval status and documentation to manufacturing, evidence, and liability. The regulatory due diligence process ends with a risk and liability report and pre-close and post-close action plans.
Regulatory Pathway & Approval Status Assessment
Validation of device classification and intended use
Review of current and planned regulatory approval routes
Assessment of submission, approval, and commitment status
Identification of approval dependencies impacting deal timelines
Markets covered: US FDA, EU MDR/IVDR, UKCA, CDSCO, SFDA, and other global jurisdictions
Compliance & Documentation Review
Evaluation of technical documentation and dossier completeness
ISO 13485 and Quality Management System compliance assessment
Review of labeling, IFU, claims, and promotional compliance risks
Assessment of Post-Market Surveillance and vigilance obligations
Manufacturing & Quality System Due Diligence
Review of manufacturing licenses and site authorizations
QMS maturity assessment against certification scope
Inspection readiness analysis (FDA, Notified Body, CDSCO)
Review of audit observations, CAPAs, and open nonconformities
Identification of process validation and production control risks
Predicate, Benchmark & Regulatory Precedent Analysis
Identification of comparable approved devices
Review of substantial equivalence and regulatory precedents
Competitive regulatory positioning and approval learnings
Clinical & Evidence Assessment
Review of clinical, performance, usability, and real-world data
Alignment with FDA, EU MDR/IVDR, and global evidence expectations
Identification of evidence gaps and post-market study risks
Regulatory Risk & Liability Assessment
Classification of risks as critical, major, or manageable: performance, usability, and real-world data
Identification of regulatory non-compliance exposure
Approval dependency and enforcement risk evaluation
Estimation of remediation effort, cost, and timeline
Conducting thorough medical device regulatory due diligence requires meticulous evaluation of approval pathways, quality management maturity, and clinical evidence integrity. By identifying hidden compliance gaps, manufacturing liabilities, and regulatory dependencies prior to transaction closure, we protect investor valuation and establish clear pre-close and post-close risk mitigation action plans.
What Sets Us Apart as a Regulatory Due Diligence Consultant
Global exposure, structured thinking, and execution-ready expertise
Global Regulatory Expertise Across US, EU, UK, India, GCC & Emerging Markets
Coverage of Medical Devices & IVDs Across All Risk Classes
Experience Supporting Investment, M&A & Strategic Transactions
Proven Insights Aligned with Real-World Approvals & Inspections
Regulatory due diligence for medical device investments and transactions – we support investors and companies with comprehensive regulatory due diligence to assess compliance risks and market readiness. Each engagement includes a detailed due diligence report covering risk classification, market-wise regulatory status, approval pathways, and the impact of regulatory risks on valuation and transaction timelines, along with clear pre-close and post-close regulatory action plans.
As a regulatory due diligence consultant, Operon supports investors and companies in M&A, investment, and strategic transactions. Our regulatory compliance due diligence spans the US, EU, UK, India, GCC, and emerging markets, and covers medical devices and IVDs across all risk classes. For remediation after the report, see our medical device regulatory consulting.
Operon Regulatory Compliance Due Diligence Advantage
Identify regulatory risks, approval gaps, and compliance exposure before you invest, acquire, license, or partner, through expert, decision-grade medical device regulatory due diligence
Independent, Execution-Neutral Regulatory Assessments
Translation of Regulatory Exposure into Business & Valuation Impact
Market-Wise, Approval-Focused Risk Visibility
Practical Remediation & Post-Transaction Planning Insights
Partnering with an expert regulatory due diligence consultant removes uncertainty during high-stakes mergers, acquisitions, and strategic investments. Our comprehensive regulatory compliance due diligence delivers independent, execution-neutral risk visibility across global markets—empowering investors and MedTech enterprises to navigate complex health authority requirements with absolute confidence and strategic clarity.
You Might Also Be Interested in
Frequently Asked Questions About Medical Device Regulatory Due Diligence
When is regulatory due diligence needed for medical device companies?
Medical device regulatory due diligence is typically conducted during M&A transactions, private equity investments, licensing agreements, or partnership evaluations to uncover hidden compliance risks before deal closure. It tests whether the target has applied due care and due diligence in regulatory compliance.
What does Operon Strategist's due diligence report cover?
Operon Strategist’s due diligence reports provide a full medical device regulatory assessment, covering regulatory pathway status, classification validation, QMS and documentation review, manufacturing compliance, predicate analysis, clinical evidence gaps, and risk classification with remediation recommendations.
How does regulatory due diligence impact deal valuation?
Regulatory due diligence translates compliance gaps, approval dependencies, and inspection risks into business impact, helping investors and acquirers adjust valuation, structure deal terms, and plan post-transaction remediation.
Does Operon Strategist support post-transaction regulatory planning?
Yes, Operon Strategist provides both pre-close risk assessment and post-close regulatory action plans to help companies address compliance gaps identified during due diligence.
Identify Regulatory Risks Before You Invest, Acquire, or Partner
Talk to a regulatory due diligence consultant
Please provide the following information and we’ll put you in touch with the right person.